1.
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
by Jiang, Peng
Nature medicine, 2018, Vol.24 (10), p.1550-1558
2.
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells
by Rauber, Simon
Nature medicine, 2017, Vol.23 (8), p.938-944
3.
Calreticulin exposure dictates the immunogenicity of cancer cell death
by Obeid, Michel
Nature Medicine, 2007, Vol.13 (1), p.54-61
4.
Systemic dysfunction and plasticity of the immune macroenvironment in cancer models
by Allen, Breanna M
Nature medicine, 2020, Vol.26 (7), p.1125-1134
5.
Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice
by Tao, Hanlin
Nature medicine, 2014, Vol.20 (11), p.1263-1269
6.
ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix
by Mayorca-Guiliani, Alejandro E
Nature medicine, 2017, Vol.23 (7), p.890-898
7.
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
by Trotta, Eleonora
Nature medicine, 2018, Vol.24 (7), p.1005-1014
8.
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
by Yu, Jiali
Nature medicine, 2021, Vol.27 (1), p.152-164
9.
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells
by Sherlock, Jonathan P
Nature medicine, 2012, Vol.18 (7), p.1069-1076
10.
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice
by Zhang, Jie
Nature medicine, 2009, Vol.15 (8), p.940-945
11.
G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis
by Wei, Tao
Cancer letters, 2016, Vol.382 (2), p.195-202
12.
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions
by Kadowaki, Takashi
Nature Medicine, 2007, Vol.13 (3), p.332-339
13.
Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis
by Falcão, Ana Mendanha
Nature medicine, 2018, Vol.24 (12), p.1837-1844
14.
Diabetes primes neutrophils to undergo NETosis, which impairs wound healing
by Wong, Siu Ling
Nature medicine, 2015, Vol.21 (7), p.815-819
15.
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
by Nikić, Ivana
Nature medicine, 2011, Vol.17 (4), p.495-499
16.
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
by Mayo, Lior
Nature medicine, 2014, Vol.20 (10), p.1147-1156
17.
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer
by Dauch, Daniel
Nature medicine, 2016, Vol.22 (7), p.744-753
18.
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
by Janelidze, Shorena
Nature medicine, 2020, Vol.26 (3), p.379-386
19.
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
by Rudalska, Ramona
Nature medicine, 2014, Vol.20 (10), p.1138-1146
20.
TLR4 enhances TGF-β signaling and hepatic fibrosis
by Seki, Ekihiro
Nature medicine, 2007, Vol.13 (11), p.1324-1332
